Neurizon Therapeutics (FRA:ECQ0) Other Net Income (Loss) : €0.01 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Neurizon Therapeutics Other Net Income (Loss)?

Neurizon Therapeutics's Other Net Income (Loss) for the six months ended in Dec. 2024 was €0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.01 Mil.

Neurizon Therapeutics's quarterly Other Net Income (Loss) declined from Dec. 2023 (€0.75 Mil) to Jun. 2024 (€0.01 Mil) and declined from Jun. 2024 (€0.01 Mil) to Dec. 2024 (€0.00 Mil).

Neurizon Therapeutics's annual Other Net Income (Loss) increased from Jun. 2003 (€-1.18 Mil) to Jun. 2004 (€0.00 Mil) but then declined from Jun. 2004 (€0.00 Mil) to Jun. 2005 (€-2.12 Mil).

Neurizon Therapeutics Other Net Income (Loss) Historical Data

The historical data trend for Neurizon Therapeutics's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics Other Net Income (Loss) Chart

Neurizon Therapeutics Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun24

Other Net Income (Loss)

Get a 7-Day Free Trial

-2.20

-1.18

-2.12

0.76

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	0.75	0.01	-

Neurizon Therapeutics Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01 Mil.

Neurizon Therapeutics Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (FRA:ECQ0) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

NUZ:Australia

Address

96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.neurizon.com

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines